Stock Track | Elevance Health Soars 5.04% Intraday After Q1 Earnings Crush Expectations, Analysts Raise Price Targets

Stock Track04-24 00:52

Elevance Health's stock surged 5.04% intraday on Thursday, extending gains following the release of its strong first-quarter financial results.

The healthcare company posted first-quarter adjusted earnings per share of $12.58, significantly surpassing the IBES consensus estimate of $10.80 by approximately 16.5%. This substantial earnings beat has fueled sustained buying interest in the stock since the report was released.

In response to the robust earnings, several analysts have raised their price targets on the stock. Barclays adjusted its target to $408 from $393 while maintaining an Overweight rating, Deutsche Bank lifted its target to $363 from $332, and Baird increased its target to $331 from $317.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122571726?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-24 00:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122571726","market":"nz","top_or_hot":-1,"title":"Stock Track | Elevance Health Soars 5.04% Intraday After Q1 Earnings Crush Expectations, Analysts Raise Price Targets","media":"Stock Track","content":"<p>Elevance Health's stock surged 5.04% intraday on Thursday, extending gains following the release of its strong first-quarter financial results.</p><p>The healthcare company posted first-quarter adjusted earnings per share of $12.58, significantly surpassing the IBES consensus estimate of $10.80 by approximately 16.5%. This substantial earnings beat has fueled sustained buying interest in the stock since the report was released.</p><p>In response to the robust earnings, several analysts have raised their price targets on the stock. Barclays adjusted its target to $408 from $393 while maintaining an Overweight rating, Deutsche Bank lifted its target to $363 from $332, and Baird increased its target to $331 from $317.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Elevance Health Soars 5.04% Intraday After Q1 Earnings Crush Expectations, Analysts Raise Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Elevance Health Soars 5.04% Intraday After Q1 Earnings Crush Expectations, Analysts Raise Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-24 00:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Elevance Health's stock surged 5.04% intraday on Thursday, extending gains following the release of its strong first-quarter financial results.</p><p>The healthcare company posted first-quarter adjusted earnings per share of $12.58, significantly surpassing the IBES consensus estimate of $10.80 by approximately 16.5%. This substantial earnings beat has fueled sustained buying interest in the stock since the report was released.</p><p>In response to the robust earnings, several analysts have raised their price targets on the stock. Barclays adjusted its target to $408 from $393 while maintaining an Overweight rating, Deutsche Bank lifted its target to $363 from $332, and Baird increased its target to $331 from $317.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1122571726","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122571726","pubTimestamp":1776963169,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Elevance Health's stock surged 5.04% intraday on Thursday, extending gains following the release of its strong first-quarter financial results.The healthcare company posted first-quarter adjusted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"个股追踪|Elevance Health盘中大涨5.04%Q1盈利碾压预期分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"Elevance Health's stock surged 5.04% intraday on Thursday, extending gains following the release of its strong first-quarter financial results.The healthcare company posted first-quarter adjusted earnings per share of $12.58, significantly surpassing the IBES consensus estimate of $10.80 by approximately 16.5%. This substantial earnings beat has fueled sustained buying interest in the stock since the report was released.In response to the robust earnings, several analysts have raised their price targets on the stock. Barclays adjusted its target to $408 from $393 while maintaining an Overweight rating, Deutsche Bank lifted its target to $363 from $332, and Baird increased its target to $331 from $317.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122571726","isCrawlerRequest":true}